Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$1.83M
68.42K shares
What this filing means
BERNSTEIN HAROLD plans to sell 68.42K shares of MAZE THERAPEUTICS, INC. valued at approximately $1.83M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009933
Officer· President, R&D & CMO
Since Mar 2026
68.42K
Shares to sell
$1.83M
Approx. market value
16.14K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/1/2026
16.14KTotal acquired16.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Exercise of Stock Options Cash | 16.14K | — |
| Total | 16.14K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.71K
Market value
$254.5K
9/4/2026
—Completed
Units to sell
16.14K
Market value
$425.5K
9/1/2026
—Completed
Units to sell
10.29K
Market value
$270.1K
9/1/2026
—Completed
Units to sell
16.14K
Market value
$445.6K
8/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.14K
Market value
$438.7K
10/1/2026
Total
Units
68.42K
Value
$1.83M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2026 | 9.71K | $254.5K | — | Completed |
9/1/2026 | 16.14K | $425.5K | — | Completed |
9/1/2026 | 10.29K | $270.1K | — | Completed |
8/13/2026 | 16.14K | $445.6K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 16.14K | $438.7K | NASDAQ | Planned |
| Total | 68.42K | $1.83M | ||